Revolution Medicines, Inc. (RVMD)
NASDAQ·Healthcare·Biotechnology
$180.74
-1.70%
Mkt Cap $40.23B
Analyst Ratings
Buy
33
Hold
0
Sell
0
Price Target (46 analysts)
$176.08
Range $73.00 – $235.00
Implied Upside
-2.6%
Consensus $176.08 vs current $180.74
NASDAQ·Healthcare·Biotechnology
$180.74
-1.70%
Mkt Cap $40.23B
Buy
33
Hold
0
Sell
0
Price Target (46 analysts)
$176.08
Range $73.00 – $235.00
-2.6%
Consensus $176.08 vs current $180.74